Inflammatory bowel diseases and nutritional therapy

doi:10.3969/j.issn.1004-583X.2018.08.005

Clinical Focus

Previous Articles Next Articles

Inflammatory bowel diseases and nutritional therapy

1. School of Medicine, South China University of Technology, Guangzhou 510006, China;2. Guangzhou First
People's Hospital, the Second Affiliated Hospital of South China University of Technology, Guangzhou 510180, China;
3. Department of Gastroenterology, the Sixth Affiliated Hospital of Sun Yatsen University, Guangzhou 510655, China;
4.Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, the Sixth Affiliated Hospital,
Sun Yatsen University, Guangzhou 510655, China

Online:2018-08-05 Published:2018-09-10
Contact: Correspondence author: Zhi Min, Email: zhimin@mail.sysu.edu.cn

Abstract

He Huan1, 2, Zhi Min3, 4. Inflammatory bowel diseases and nutritional therapy[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2018.08.005.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2018.08.005

https://huicui.hebmu.edu.cn/EN/Y2018/V33/I8/666

[1]	Chen Xiaotian, Huo Lijuan. Meta-analysis of clinical significance of serum total bilirubin level in inflammatory bowel disease [J]. Clinical Focus, 2023, 38(8): 677-685.
[2]	Li Yingying, Li Ting, Zhang Ming, Fan Minghua, Xing Guangqun. Monitoring significance of CD4⁺ T lymphocyte count on evaluating frailty status of chronic renal failure in patients [J]. Clinical Focus, 2022, 37(3): 243-247.
[3]	Liang Xiaonan, Li Hui, Wang Dong, Zhang Xiaolan. Interpretation of the consensus on Management of Patients with Inflammatory Bowel Disease during Epidemic of Novel Coronavirus Pneumonia [J]. Clinical Focus, 2020, 35(2): 113-115.
[4]	Yao Can, Wang Rongzhen, Liu Tianxi. Correlation between level of serum klotho protein, FGF23 and nutritional status of peritoneal dialysis patients [J]. Clinical Focus, 2020, 35(10): 922-926.
[5]	Wang Lua, Tian Ronga, Zhou Weia, Niu Jianruia, Gao Maolongb. Effect of frailty on rehospitalization for acute exacerbations of COPD [J]. Clinical Focus, 2019, 34(4): 321-325.
[6]	Zhang Jianhua1a, Li Junxia1b, Liu Jing2，Wang Rongfu1a. Application of nuclear medicine to inflammatory bowel disease [J]. Clinical Focus, 2018, 33(8): 645-649.
[7]	Ge Chaoyi, Wang Huahong. Progress of nutritional support therapy in patients with inflammatory bowel disease [J]. Clinical Focus, 2018, 33(8): 650-655,660.
[8]	Tian Yu, Li Junxia, Wang Huahong. Nutritionalrelated diseases of inflammatory bowel disease [J]. Clinical Focus, 2018, 33(8): 656-660.
[9]	Tian Yu, Li Junxia, Wang Huahong. Enteral nutrition therapy and intestinal flora in patients with inflammatory bowel disease [J]. Clinical Focus, 2018, 33(8): 661-665.
[10]	Song Yan1， Yang Hu2， Jiang Kui1， Wang Bangmao1. Systematic review of thalidomide and thalidomide analogues for treatment of inflammatory bowel disease [J]. Clinical Focus, 2018, 33(5): 434-439.
[11]	Li Yue, Qian Jiaming. Study advances of inflammatory bowel disease complicated with Clostridium difficile infection [J]. Clinical Focus, 2018, 33(5): 394-397.
[12]	Wang Zekai, Hu Zhijuan, Dong Chunxia, Niu Kai, Liu Bing. Serum ghrelin and chronic kidney diseases [J]. Clinical Focus, 2018, 33(10): 849-853.
[13]	Kong Jianhua， Zhang Jie， Cui Yunjing， Hua Yingying. Comparison of two methods of nutritional assessment in elderly patients with diabetic nephropathy [J]. Clinical Focus, 2017, 32(4): 301-304.
[14]	Lei Lei1，2， Zhang Xiaolan1， Yin Fengrong1. Opportunistic infections and inflammatory bowel disease [J]. Clinical Focus, 2016, 31(8): 865-868.
[15]	Niu Weiwei， Zhao Dandan， Huo Xiaoxia. Helicobacter pylori infection and inflammatory bowel disease [J]. Clinical Focus, 2016, 31(8): 861-964.

Inflammatory bowel diseases and nutritional therapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments